Paid Clinical Trials in Adelaide, South Australia for Healthy Volunteers
10 recruitingAdelaide, South Australia, Australia
Showing 1–10 of 10 studies
Recruiting
Phase 1Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Healthy Volunteers, Pulmonary Arterial Hypertension
Novartis Pharmaceuticals232 enrolled85 locationsNCT06649110
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases
Healthy ParticipantsHealthy VolunteersAutoimmune Diseases+1 more
BeiGene211 enrolled13 locationsNCT06342713
Recruiting
Phase 1
Study of BW-50218 in Healthy Participants
Healthy Participants Study
Shanghai Argo Biopharmaceutical Co., Ltd.60 enrolled2 locationsNCT07401472
Recruiting
Phase 1
A Phase 1 Study of FZ008-145 in Healthy Subjects.
Healthy
Guangzhou Fermion Technology Co., LTD190 enrolled1 locationNCT06685809
Recruiting
Phase 2
A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of Aging in Healthy Adults and Cancer Survivors
Cancer SurvivorsElderlyHealthy Participant
GI Innovation, Inc.15 enrolled2 locationsNCT07363057
Recruiting
Phase 1
A Pharmacokinetic Study of YN001 in Healthy Participants
Healthy Volunteers
Beijing Inno Medicine Co., Ltd.24 enrolled1 locationNCT07190885
Recruiting
Phase 1
A Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN110755
Healthy
Voronoi, Inc24 enrolled1 locationNCT07141381
Recruiting
Phase 1
A Phase 1 Study of S-1117
Healthy Volunteer
Seismic Therapeutic AU Pty Ltd96 enrolled1 locationNCT06828393
Recruiting
Phase 1
A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis
Active Ulcerative ColitisActive Ulcerative Colitis (UC)Healthy Adult Volunteers
NIBEC Co., Ltd.24 enrolled1 locationNCT06681389
Recruiting
Phase 1
First-into-human Study of NS-136 in Healthy Subjects
Healthy Subjects
NeuShen Therapeutics76 enrolled2 locationsNCT06345703